EU pathway for improve rare disease identification and treatment

New EU platform to support better rare disease diagnosis and treatment

The European Commission is launching a new online knowledge-sharing platform to support better diagnosis and treatment for more than 30 million Europeans living with a rare disease.

Currently a vast amount of data on patients with specific conditions is scattered across Europe in about 600 'registries' – databases that hold information on patients with specific conditions. Data is not collected EU-wide and there are no shared standards to analyse the information that is available on rare diseases. The new European Platform on Rare Diseases Registration will bring this data together supporting the quality research that can enhance diagnosis and treatment outcomes - helping to improve the lives of patients and their families.

READ MORE …

EU Genomics sector has some reliable bets

10 European Genomics Companies to Watch Out For

Next generation sequencing has revolutionized the biotech industry and genomics technology has changed dramatically over the last few years. There are many interesting European genomics companies, but here are 10 we thought especially worthy of mention.

READ MORE …

A European take on CRISPR corn

Boosting corn yields with CRISPR-carrying pollen

Scientists have developed a single-step gene editing process that can increase corn yields.
The new technique uses pollen to transfer the components of CRISPR-Cas9 into another plant allowing them to produce gene edited corn, a process previously hindered by the thick cell walls of many plants, such as corn and wheat. Results of the first set of experiments were published on 4 March in Nature Biotechnology.

READ MORE …

Dante Labs starting first of it's new powerhouse sequencing clinic chain

Dante Labs Announces First European Clinic With Integrated 30X Whole Genome Sequencing in Standard Clinical Care

Dante Labs takes the first step of its ambitious project to integrate high coverage genome sequencing in clinical care in clinics and hospitals. 

Dante Labs has announced the first of hundreds of European clinics which will integrate whole genome and whole exome sequencing in standard clinical care, further making personalized medicine a standard within the European health care system.

The clinic, "Villa Letizia," is located in L’Aquila, Italy, and is the selected destination for patients across the entire Mediterranean region. Patients will receive 100X whole exome or 30X whole genome sequencing with premium turnaround time and personalized reports as part of their standard clinical care.

READ MORE …